These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17373282)

  • 1. [IV iron or oral iron in anaemic patient with CKD].
    Frimat L; Thilly N; Boini S
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S347-9. PubMed ID: 17373282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
    Macdougall IC
    Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
    Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S; Naudeer S
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron management in nondialysis-dependent CKD.
    Fishbane S
    Am J Kidney Dis; 2007 Jun; 49(6):736-43. PubMed ID: 17533016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia in older people with chronic heart failure: The potential cost.
    Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
    Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intravenous iron in patients with cancer-related anaemia.
    Littlewood TJ; Alikhan R
    Br J Haematol; 2008 Jun; 141(6):751-6. PubMed ID: 18410455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
    Artunc F; Risler T
    Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?
    Rizvi S; Schoen RE
    Am J Gastroenterol; 2011 Nov; 106(11):1872-9. PubMed ID: 22056566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in Catalonia: MICENAS I study.
    Cases-Amenós A; Martínez-Castelao A; Fort-Ros J; Bonal-Bastons J; Ruiz MP; Vallés-Prats M; Coll-Piera E; Galcerán-Gui JM;
    Nefrologia; 2014; 34(2):189-98. PubMed ID: 24658193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
    Garneata L
    J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of different tests of the efficacy of iron supplementation].
    Ladrière M
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S333-6. PubMed ID: 17373279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
    Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
    Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of anemia in chronic kidney disease].
    López Gómez JM
    Nefrologia; 2008; 28 Suppl 3():63-6. PubMed ID: 19018741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.